Saeed Sadeghi, MD

Articles by Saeed Sadeghi, MD

Jamile Shammo, MDMyelodysplastic Syndromes | November 18, 2024
Is ESA use and performance in the academic setting reflective of real-world MDS practice? Our expert panel discusses.
Jamile Shammo, MDMyelodysplastic Syndromes | November 18, 2024
The panel discusses how to best implement such a monitoring system to address a widespread issue of suboptimal dosing.
Jamile Shammo, MDMyelodysplastic Syndromes | November 15, 2024
The panel led by Jamile Shammo, MD, reacts to results from a claims database study comparing the agent with ESAs.
Jamile Shammo, MDMyelodysplastic Syndromes | October 29, 2024
The expert panel discussion led by Jamile Shammo, MD, also noted differences in cell line suppression by mutational profile.
Jamile Shammo, MDMyelodysplastic Syndromes | October 23, 2024
Jamile Shammo, MD, leads a roundtable discussion on the effect of molecular data incorporation and goals in treatment.
Jamile Shammo, MDMyelodysplastic Syndromes | October 23, 2024
The expert panel led by Jamile Shammo, MD, tells how trial data and their clinical experiences inform their use of the agent.